Breaking News
Get 45% Off 0
🤯 +96%, +62%, +40%: These AI-picked stocks are soaring!
See the list

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Oracle Posts Best Revenue Growth In 2 Years: ETFs In Focus By Zacks Investment Research - Mar 12, 2020

After the closing bell yesterday, software giant Oracle (NYSE:ORCL) reported better-than-expected fiscal third-quarter 2020 results. The company beat the Zacks Consensus Estimate for earnings and...

Range Resources (RRC) Catches Eye: Stock Jumps 6.7% By Zacks Investment Research - Mar 12, 2020

Range Resources Corporation (NYSE:RRC) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands...

Harrow Health (HROW) Q4 Earnings And Revenues Lag Estimates By Zacks Investment Research - Mar 12, 2020

Harrow Health (HROW) came out with quarterly earnings of $0.10 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.77 per share a year ago. These...

Disney (DIS) Shuts Theme Parks As Coronavirus Threat Looms By Zacks Investment Research - Mar 12, 2020

Disney (NYSE:DIS) is down 36.5% year to date on concerns about lost profits from the lockdown of its theme parks due to the coronavirus outbreak.The company is closing Walt Disney World, its...

5 Blue-Chip Tech Stocks To Buy Amid Coronavirus Sell-Off By Zacks Investment Research - Mar 12, 2020

The pandemic coronavirus has pushed the stocks into bear market territory. All three major indices, namely the Dow Jones, the S&P 500 and the Nasdaq suffered heavy losses on Mar 12 as the panic...

FBIOX Or FBDIX: Which Biotech Fund Should You Buy? By Zacks Investment Research - Mar 12, 2020

The biotechnology industry is in the limelight right now owing to the novel coronavirus. After all, as most biotechnology companies around the globe rush to formulate a vaccine in a bid to cure the...

Adobe (ADBE) Q1 Earnings Top, Coronavirus Weighs On Guidance By Zacks Investment Research - Mar 12, 2020

Adobe Inc. (NASDAQ:ADBE) reported first-quarter fiscal 2020 non-GAAP earnings of $2.27 per share, surpassing the Zacks Consensus Estimate of $2.22. The figure decreased 0.9% sequentially but...

3 Dividend Mutual Funds To Ride Coronavirus Fears By Zacks Investment Research - Mar 12, 2020

The impact of the novel coronavirus on economies around the world has been no less than catastrophic. In the United States, major market indexes took a steep plunge in recent weeks and the downturn is...

JinkoSolar's $100M Share Repurchase Program Gets Approval By Zacks Investment Research - Mar 12, 2020

JinkoSolar Holding Company Limited (NYSE:JKS) recently announced that its board of directors approved a share repurchase program. This authorizes the solar module manufacturer to repurchase up to...

Coronavirus Turmoil Takes A Toll On Global 5G Rollouts   By Zacks Investment Research - Mar 12, 2020

The coronavirus (COVID-19) pandemic, which has already resulted in considerable human suffering and a major economic disruption, has rattled investors across the globe. The effects of production...

Continue with Apple
Continue with Google
or
Sign up with Email